The minimum antibiotic concentrations for selecting an R plasmid in vivo were determined in germfree mice colonized by two isogenic strains of Escherichia coli, one of which carried an R plasmid. Seventy groups of three gnotobiotic mice were given low doses of ampicillin, colistin, flumequin, gentamicin, tetracycline, or streptomycin via drinking water for 2 weeks. The equilibrium between susceptible and resistant populations of bacteria was monitored daily in feces and compared with that of control mice given pure water. This model yielded reproducible data, and dose and response were strongly correlated. The minimum selecting doses ranged from 0.9 to 12.8 ,ug/ml of water, depending on the antibiotic and the R plasmid. The use of mathematical models and complementary in vitro experiments accounted for the effect of the low antibiotic levels.
Antibiotic residues may be found in meat or milk after antimicrobial chemotherapy (19) . Surveys indicate that these residues are of rare occurrence and at concentrations generally between 0.1 and 1 ,ug/g (27) : for example, an antibiotic could be detected in 5.3% of the pig and calf carcasses in the United States in 1973, and 81% of these contaminated carcasses contained less than 1 pg of antibiotic (usually streptomycin) per g of meat (26) . Can these residues be a hazard for the human consumer? What is the no-effect level of an antibiotic on the proportion of fecal R-plasmid-bearing bacteria? To answer these questions, experiments have been conducted in human volunteers and in vitro, but their results appear to be contradictory.
In human volunteers, per os administration of 1.5 mg of ampicillin or 1 mg of oxytetracycline per day failed to produce any significant effect on resistant bacteria (1, 4) . When volunteers were given low levels of oxytetracycline for long periods, resistant enterobacteria occurred sporadically in some of the individuals who ingested 10 mg of the drug per day, but smaller intakes had no effect (13) . However, because of contaminations from food, the concentration of resistant Escherichia coli in feces varies enormously in humans. Thus, in the same volunteer it ranged from an undetectable level to a level at which resistant bacteria overcome susceptible E. coli (4, 5) . Hence, a very large sample of volunteers would be required to evidence any significant change in the level of resistance in human gut flora.
In a continuous-flow culture of three clones of E. coli K-12 strains, one of which carried an R plasmid, the minimum antibiotic concentration that selected an R plasmid was found to be 0.25 ±g/ml (15) . However, this in vitro model did not take into account three interfering ecological factors: in vivo, antibiotic residues are absorbed or inactivated; the drug may alter the dominant anaerobic microflora; and the ecological conditions are strict anaerobiosis, low flow rate, and limiting substrate (3) . There is good evidence that bacteria multiply much more slowly in an experimental animal than in vitro. The discrepancies between the results of in vitro and in vivo experiments.
To overcome the experimental difficulties encountered in studies of humans, animal models have been used, with the following results. (i) A selective pressure was demonstrated in beagles given food containing 10 pLg of oxytetracycline per g but not with food containing 2 p.g of oxytetracycline per g (24) . (ii) When germfree mice were dosed with the complex fecal flora of a human donor, their fecal flora was similar to that of the human donor (22) . When such gnotobiotic mice were continuously given 0.5 Fg of chlortetracycline or ampicillin per ml of water, a mean 30-fold increase in the proportion of resistant E. coli was observed in their feces, compared with the levels for control mice harboring the same flora (4). This antibiotic level may correspond to that ingested by a human consuming 150 g of meat containing 3 p.g of residue per g (4) . The main drawback of this last experimental system is that it is impossible to obtain exactly the same flora twice, and hence to duplicate an experiment, because of the variability of the human donor flora.
In this study, we determined the minimum antibiotic concentrations selecting a resistance plasmid in vivo by using a new animal model. It combined germfree mice with two isogenic strains of E. coli, one of which carried an R plasmid. The gnotobiotic mice were given, via drinking water, small doses of ampicillin, colistin, flumequin, gentamicin, tetracycline or streptomycin, antibiotics which are widely used in veterinary practice. With this simple model, reproducible data were obtained, and the minimum selecting doses ranged from 0.9 to 12.8 jg/ml of water. The use of mathematical models and complementary in vitro experiments enabled us to account for the effects of these doses.
MATERIALS AND METHODS Bacterial strains. E. coli plasmid-free EMO was used in all experiments. It was isolated from the stool of a healthy human and cured of a cryptic plasmid. It was susceptible to all the antibiotics tested, it did not carry any chromosomal marker of resistance but could be detected by its ability to ferment raffinose, and it did not contain any covalently closed circular form of DNA (9) . In most experiments, we used an R-plasmid-bearing strain obtained by conjugating the EMO strain with a multiresistant strain isolated from ANTIMICROB. AGENTS CHEMOtHER. human urine. It carried the pYD1 conjugative plasmid, which confers resistance to ampicillin, gentamicin, streptomycin, tetracycline, and 10 other antibiotics. This plasmid was 72 to 79 megadaltons in size when determined by agarose gel electrophoresis or contour length measurement (10) . The in vivo elimination of a pYDi-bearing strain by its plasmid-free counterpart has been demonstrated previously (9) .
Other plasmid-bearing strains were obtained by mating strain EMO with tetracycline-resistant E. coli strains obtained in our laboratory either from collections ( For the control groups, the drinking water in the isolators was drug free, and for the experimental groups, it was supplemented with ampicillin, colistin, flumequin, gentamicin, tetracycline, or streptomycin, at concentrations ranging from 0.5 to 256 jig/ml. In all, 70 experiments were conducted, one on each of 70 groups of three mice. Antibiotic concentrations in drinking water and feces were assayed by a bacteriological method. The number of total and resistant E. coli organisms in the feces of the mice was determined daily for 10 to 15 days by comparative plate counting. The kinetics of the R-plasmid-bearing E. coli populations in the experimental and control groups were compared.
Gnotobiotic mice. Two hundred and ten adult OF1 germfree mice (IFFA Credo, Lyon, France) were maintained in plastic isolators, fed ad libitum a commercial diet sterilized by irradiation (4 Mrad) , and supplied with autoclaved acidified drinking water (pH 2.5). Before the start of an experiment, three mice were transferred into a separate isolator. After confirmation that they were germfree or monocolonized (i.e., germfree but harboring a single pure strain), the mice were given 0.5 ml of a calibrated inoculum at 11 a.m. It was administered directly into the stomach by intubation. Freshly voided feces were collected at the anuses of the mice 5 days a week at 10 a.m., and the pooled fecal pellets were processed within 30 min of collection. Bacterial counts. Fresh pooled feces were diluted 10-fold in sterile saline, and 0.2-ml fractions were plated onto deoxycholate agar (DCA; Difco) in petri dishes containing either no antibiotic or 20 jig of tetracycline per ml of agar. The total viable number of E. col/ isolates per gram of fresh feces was determined from drug-free DCA plates, and the number of resistant E. coli isolates was determined from the drug-supplemented plates. During each experiment, we checked twice that there were the satne numbers of fecal tetracycline-resistant bacteria and of streptomycin-and ampicillin-resistant bacteria. Hence, the number of tetracycline-resistant bacteria was considered a good indicator of the number of plasmid-bearing bacteria. We also checked that the DCA medium and the antibiotics tested against E. coli strains had no synergistic inhibitory effects. Results were expressed as the decimal logarithms of the number of bacteria.
Antibiotic administration and assays. Except for the ampicillin, which was given every 2 days, the antibiotics were added to the drinking water twice a week, always after sterilization by filtration (pore size, 0.45 jum). The supplemented drinking water samples were assayed by the cylinder plate method with Bacillus subtilis (or with Bacillus cereus for tetracycline). Fecal samples were assayed for their antibiotic concentrations after 1/3 dilution and centrifugation at 800 x g for 5 min. Feces were diluted in distilled water (pH 6.8 for ampicillin and free tetracycline), in pH 4.5 buffer for total tetracycline, or in pH 7.9 buffer for streptomycin and gentamicin (19) . Fecal supernatants were assayed in a 100-jil stainless steel cylinder with the above-mentioned germs.
In vitro experiments. Strains were grown in a liquid medium containing, per liter, 2 g of yeast extract (Difco), 2 g of casein hydrolysate (Difco), 4 g of NaCl, 0.5 g of KH2PO4, and 1.5 g of K2HPO4 (pH 7.0). A log-phase culture of the strain tested was inoculated in 30 ml of the medium and incubated for 24 h at 37°C in a shaking water bath. Samples were taken every 30 min and measured for optical density at 400 nm. The number of CFU was determined on DCA plates at 0, 2, 8, and 24 h. Data were plotted and computerized to determine curve coefficients.
Mathematical models. The competition between the plasmid-free and plasmid-bearing strains in the guts of the mice was simulated by the mathematical model proposed by Freter (11) with some modifications (3). In this model, the number of newly formed plasmid-free bacteria per unit of time is augmented by the growth and reduced by the flow rate washout, and these changes can be formalized by the following equation: dNs/dt = Ns(Ws -P) (1) where N. is the number of susceptible plasmid-free bacteria per gram of gut content, dNj/dt indicates the differentiation of NS with respect to time, 'K is the growth rate of the susceptible bacteria, and p is the flow rate due to intestinal transit. dNidt = Nr ('K -P) (2) is the same equation applied to the number of resistant plasmid-bearing bacteria per gram, Nr, which is augmented by the growth rate, f,-, and reduced by the flow rate, p. (4) llr= Lr L/(Ksr + L) (5) where 4is and 4jr are the growth rates of susceptible and resistant bacteria, respectively, V-s and pL, are the maximum growth rates (at the optimal level of the limiting substrate), and Kss and Ksr are the saturation constants (which are numerically equal to the substrate concentration at which half the maximum growth rates are obtained). We previously built more sophisticated models which took into account the plasmid transfer and segregation (16) and the attachment of bacteria to the intestinal wall (11), but these factors appeared to be of minimal influence in the present study. To simulate in vitro batch experiments, the present model was also used in simplified form by setting the flow rate at zero.
A computer program was devised and used to evaluate the data from in vivo and in vitro experiments by numerical simulation methods. It was based on a fifth-order RungeKutta kernel, written in Turbo Pascal, and used on an 8086 XT microcomputer. The numerical values of the parameters were taken from data previously obtained in vitro (14) or in vivo (11) and modified by trial and error to fit the present experimental data.
RESULTS
Equilibrium in the absence of antibiotic. When plasmid-free E. coli EMO alone was inoculated into germfree mice, it became established 1 day later at the high population level of i09-5 cells per g of feces. After subsequent inoculation of these monocolonized mice with a tetracycline-resistant strain of E. coli EMO containing either R plasmid RP4 or R270, the resistant strains became dominant and rapidly outnumbered the plasmid-free strain. In contrast, when the mice monocolonized by the plasmid-free strain were given E. coli EMO harboring plasmid pCl or pYD1, these resistant populations were antagonized by EMO and their number slowly decreased (Fig. 1, CON) . This control experiment was repeated 10 times with pYD1 and 4 times with pCl ( Table 1) .
Effect of antibiotics on kinetics. When 2 p.g of streptomycin per ml was added to the drinking water of mice dicolonized by the plasmid-free strain and the strain bearing plasmid pYD1, the number of resistant bacteria in feces increased slowly (Fig. 1, EXP) . With 4 ,ug of streptomycin per ml, the population of resistant bacteria grew rapidly, and after 6 days of drug administration, the plasmid-bearing cells outnumbered the plasmid-free cells. Similar kinetics were observed with ampicillin, gentamicin, and tetracycline (data not shown).
Minimum selecting level. lin, gentamicin, tetracycline, and streptomycin increased the number of resistant bacteria (Table 1) , with a strong correlation between the number at day 5 and the log2 of the drug concentration in water (r ranged from 0.86 to 0.99). The minimum selecting level was defined as the drug concentration in water which led to a resistant bacterial population of 105 bacteria at day 5, which corresponds to a 10-fold increase in the resistant population compared with that of the inoculum and to a 100-fold increase compared with the control group. Minimum selecting levels were, per ml of drinking water, 0.9 p.g of streptomycin, 1 pg of ampicillin, 2.3 ,ug of gentamicin, 6.5 pLg of tetracycline with the pYD1 plasmid, and 12.8 p.g of tetracycline with the pCl plasmid.
To assess the effects of nonselecting antibiotics by using the same animal model, colistin and flumequin were administered to groups of mice via the drinking water at concentrations ranging from 1 to 64 ,ug/ml (flumequin) or 1 to 256 pLg/ml (colistin). In 13 experiments lasting 2 weeks or more, these drugs did not reduce the level of the EMO plasmid-free strain, nor did they increase the fecal excretion of pYD1-bearing bacteria (data not shown). Also, in the three groups of mice which were given more than 64 p.g of colistin per ml of water, the plasmid-bearing bacteria were eliminated faster than in the control groups and no plasmid-bearing E. coli cells were detected in feces at day 5. Antimicrobial concentrations in feces. Antibiotic concentrations were measured in drinking water and in fecal samples from some experimental groups of mice. In the water, a mean proportion of 95% of the theoretical dose was found (Table 2) . In fecal samples, the tetracycline and streptomycin concentrations averaged 34% of the concentration in the water, and gentamicin and ampicillin concentrations averaged 13% ( Table 2 ). The groups of mice given water supplemented with 8 jig of ampicillin per ml constituted an exception, because only 49% of the dose was found in the water and only 2% of the concentration in the water was found in the feces. This might be due to antibiotic absorption or to destruction by the resistant strain, both of which have already been studied in gnotobiotic animals (7) . A complementary experiment showed that an ampicillin dose of 1 c This datum for control groups was copied from the first tetracycline column, since experiments were not repeated. mg per day was detoxified in seven gnotobiotic mice harboring a resistant E. coli strain, since the concentration of ampicillin in ceca was 1.3% of the concentration in the drinking water, versus 50% in eight mice monocolonized by a susceptible strain (full data not shown). The very low ampicillin concentration in mouse feces may thus reflect the concentration in the cecum (Table 2 ). Since streptomycin, gentamicin, and tetracycline are minimally absorbed from the large intestine and are not inactivated outside the bacterial cells, the antibiotic concentration in the cecum can be about half the concentration in feces because of water absorption in the colon. The concentration of free tetracycline in feces which was assayed in distilled water, which was likely to be the only active fraction of the antibiotic, was about 20% of the total concentration. This difference could be due to the chelation of the tetracycline by divalent cations, which inhibit the antibiotic (23) .
In vitro experiments. In liquid medium, the MICs for the plasmid-free E. coli strain ranged between 1 and 4 ,ug/ml ( Table 3 ). The effect of low antibiotic concentration on the bacterial growth rate and the number of bacteria at equilibrium was measured in batch cultures. In media containing more than 1 ,ug of ampicillin, gentamicin, or colistin per ml, there was a large discrepancy between the number of bacteria estimated on the one hand from the optical density after 8 h and 24 h of incubation and on the other hand by plate counting after the same incubation periods, as also reported by Lorian (17) . Subinhibitory concentrations of antibiotics reduced the total number of bacteria at equilibrium compared with that in the control (Table 3) . At concentrations of 2 ,g/ml and above, the population increased for 1 or 2 h and then decreased (data not shown). The in vitro plasmid transfer rate constant between plasmid-bearing EMO and rifampin-resistant EMO, in exponentially growing cultures, was 3.0 x 10-11 ml per cell per h for plasmid R270, 2.6 x 10-12 ml per cell per h for RP4, 1.1 x 10-12 ml per cell per h for pYD1, and 7.7 x 10-13 ml per cell per h for pCl.
Mathematical modeling. The mathematical model matched the population levels observed in experiments conducted on control groups of mice (Fig. 1, CON) . We tested four possible effects of low antibiotic concentrations on the in vivo equilibrium between plasmid-free and plasmid-bearing strains (the antibiotic is represented in the following equations by AB, as a function of concentration). For this purpose, it was alternatively assumed that the drug would kill some plasmid-free cells, thus changing equation 1 to: dNsldt = N,(4S -p -AB) (6) reduce the ability of susceptible cells to use a limiting substrate, hence increasing the saturation constant and changing equation 4 to: = [S LI(Ks, + AB) + L) (7) reduce the maximum growth rate of plasmid-free cells (I.), thus changing equation 4 to: *, = (, -AB) -LI(Kss + L) (8) or enhance the rate of R plasmid transfer from resistant to susceptible strains, leading to a more complex model that we also tested (equations not shown).
Although it was not necessary to imagine more sophisticated explanations, we were unable to eliminate any one of these hypotheses on the basis of numerical simulations of in vivo competition, since the results obtained with all these drug effect models matched the experimental data obtained in vivo. For example, the effect of 2 jig of streptomycin was simulated by setting the numerical value of the parameter AB at 0.06 per h in equations 6 (Fig. 1, EXP) In other words, the mathematical model shows that a small antibiotic concentration which is not sufficient either to reduce the in vitro growth values significantly or to eliminate a susceptible bacterium from the guts of monocolonized mice can suffice to permit the outgrowth of an R-plasmidbearing strain in dicolonized mice.
DISCUSSION
The experimental model proposed here is simple and gives reproducible results. The three main advantages of gnotobiotic models over previous experimental situations are the isolation from the bacterial environment, ensuring the absence of contamination; the use of a well-defined flora, permitting truly identical control and experimental groups of mice as well as identical sequential experiments; and the physiological ecological conditions arising from the in vivo situation. However, although the principles that govern bacterial interactions in the mouse intestine may also be expected to have their counterpart in humans, the ecological situation of E. coli strains in the gut of a germfree mouse is far from the situation of bacteria in the guts of humans because of the absence of dominant anaerobes. Consequently, the model would be improved if a known flora of human origin were inoculated into the digestive ecosystem of the mouse, in order to mimic the role of the dominant anaerobic flora in humans.
The RP4 and R270 plasmids conferred an apparent ecological advantage on the carrying strain in the dicolonized mice drinking pure water, while the pYD1 and pCl plasmids were detrimental to the bacteria. The advantage thus afforded by some plasmids to the host bacteria might be due to encoded plasmid proteins, an adaptation period of the bacterium-plasmid association conferring increased fitness of the host (2) . However, most R-plasmid-bearing strains are disadvantaged compared with their plasmid-free counterparts, probably because their in vivo growth rate is reduced (28) by the rise in the saturation constant for the limiting substrate (11) . Then, the dominance of RP4 and R270 is likely due to a high rate of plasmid transfer leading to the spread of the plasmid to susceptible cells, as previously shown in gnotobiotic mice colonized by E. coli K-12 strains with chromosomal markers, one of which bore plasmid R270 (6) . We chose here to study isogenic strains, because of the detrimental effect of chromosomal mutations on strains in vivo (6, 21) . It was therefore not possible to detect in vivo plasmid transfer, since the parent strains had no markers. The in vitro values of transfer rate constant show that the four plasmids are conjugative and repressed for transfer (16) . Plasmids pYD1 and pCl, which fail to predominate in the gut, show lower frequencies of transfer in vitro than R270 and RP4, though the difference between RP4 and pYD1 was small. However, these differences are only indicative of what might take place in the gut, since the value of the transfer rate constant in exponentially growing cultures is considerably greater than its corresponding value in slowly dividing cultures or in mouse cecal flora (11, 16 ).
An attempt to explain the in vivo effect of low antibiotic levels on the equilibrium among E. coli strains was made by comparing the antibiotic concentrations in feces and the in vitro susceptibility of the strain. For example, the minimum selecting level for tetracycline in vivo was 6.5 ,ug/ml of water, which produced a free concentration of 0.5 [Lg/g in feces (calculated from the data in Table 2 ). This concentration is one-half the MIC for the plasmid-free strain and was found to reduce the number of bacteria in vitro ( Table 3) . The same speculation might well apply to gentamicin, but for streptomycin and ampicillin the calculated concentrations in feces which corresponded to the minimum selecting level in vivo were about 1/20 of the MICs and produced no detectable effect in vitro. In studies by Lorian and De Frietas (18) , the minimal concentration of ampicillin and gentamicin which reduced the number of viable cells 10-fold was about 1/20 of the MIC for E. coli. This might explain the in vivo effect of the low drug concentrations. For all the tested drugs, however, the concentration which selected resistance in vivo was less than the MIC and did not directly eliminate the susceptible bacteria from the gut. A possible explanation for this phenomenon was provided by modeling the population dynamics.
Garber (12) has proposed a mathematical model, based on the logistic equation, to simulate the effects of antibiotics on the growth of mixed bacterial populations. This model, however, did not explicitly take into account the flow due to VOL. 33, 1989 on August 14, 2017 by guest http://aac.asm.org/ Downloaded from
